Velariq 1 mg/ml Lösung zur intravesikalen Anwendung

Country: Switzerland

Language: Italian

Source: Swissmedic (Swiss Agency for Therapeutic Products)

Active ingredient:

oxybutyninum

Available from:

Salmon Pharma GmbH

ATC code:

G04BD04

INN (International Name):

oxybutyninum

Pharmaceutical form:

Lösung zur intravesikalen Anwendung

Composition:

oxybutynini hydrochloridum 10.04 mg corresp. oxybutyninum 9.11 mg, natrii chloridum, aqua ad iniectabile, acidum hydrochloridum dilutum, ad solutionem pro 10 ml.

Class:

B

Therapeutic group:

Synthetika

Therapeutic area:

Zur Unterdrückung einer neurogenen Detrusorüberaktivität

Authorization status:

zugelassen

Authorization date:

2023-09-11

Patient Information leaflet

•
Ricerca
•
Cerca SAI
•
Nuove omologazioni
•
Testi modificati
•
Scaricare
•
Aiuto
•
Accedi
IT
DE
FR
EN
AIPS - RICERCA INDIVIDUALE
Piattaforma di notifica elettronica per la vigilanza (ElViS)
Nessun risultato

Summary of Product characteristics

•
Ricerca
•
Cerca SAI
•
Nuove omologazioni
•
Testi modificati
•
Scaricare
•
Aiuto
•
Accedi
IT
DE
FR
EN
AIPS - RICERCA INDIVIDUALE
Piattaforma di notifica elettronica per la vigilanza (ElViS)
Nessun risultato